In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital

In-vitro activity of tigecycline against multidrug-resistant Gram negative bacteria: The experience of a university hospital

The emergence of multidrug-resistant Gram negative bacteria has given rise to significant therapeutic challenges. These pathogens may have developed resistance to tigecycline, which is an alternative antibiotic used empirically in the treatment of serious infections.The objectives of this study were...

Full description

Bibliographic Details
Main Authors:	Z. Elnasser, R. Elsamarneh, H. Obeidat, Z. Amarin, S. Jaradat, N. Kaplan
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Journal of Infection and Public Health
Subjects:	Tigecycline Multidrug resistance Resistance genes Gram negative bacteria
Online Access:	http://www.sciencedirect.com/science/article/pii/S1876034120307693

Similar Items

Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
by: Stefania Stefani, et al.
Published: (2016-11-01)

The Tigecycline Evaluation and Surveillance Trial; assessment of the activity of tigecycline and other selected antibiotics against Gram-positive and Gram-negative pathogens from France collected between 2004 and 2016
by: Jean-Winoc Decousser, et al.
Published: (2018-05-01)

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial
by: Zhijie Zhang, et al.
Published: (2018-12-01)

Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria
by: Andrea Vila Domínguez, et al.
Published: (2020-01-01)

Predictive factors for multidrug-resistant gram-negative bacteria among hospitalised patients with complicated urinary tract infections
by: Aina Gomila, et al.
Published: (2018-09-01)

Tigecycline activity against metallo-β-lactamase-producing bacteria
by: Simit Kumar, et al.
Published: (2013-10-01)

Ceftazidime-avibactam: new rules for the game against multidrug-resistant gram-negative bacteria
by: Kozlov R.S., et al.
Published: (2018-02-01)

Benzydamine Reverses TMexCD-TOprJ-Mediated High-Level Tigecycline Resistance in Gram-Negative Bacteria
by: Ziwen Tong, et al.
Published: (2021-09-01)

Epidemiology and molecular characterization of multidrug-resistant Gram-negative bacteria in Southeast Asia
by: Nuntra Suwantarat, et al.
Published: (2016-05-01)

Short antimicrobial peptidomimetic SAMP-5 effective against multidrug-resistant gram-negative bacteria
by: Eun Young Kim, et al.
Published: (2021-07-01)

Potent Broad-Spectrum Antibacterial Activity of Amphiphilic Peptides against Multidrug-Resistant Bacteria
by: Yuan Liu, et al.
Published: (2020-09-01)

Prevalence of multidrug-resistant Gram-negative bacteria cases at admission in a multispeciality hospital
by: Vasant Nagvekar, et al.
Published: (2020-09-01)

Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline
by: Sima Babaei, et al.
Published: (2021-07-01)

Risk for subsequent infection and mortality after hospitalization among patients with multidrug-resistant gram-negative bacteria colonization or infection
by: Wen-Pin Tseng, et al.
Published: (2018-07-01)

Burden of extensively drug-resistant and pandrug-resistant Gram-negative bacteria at a tertiary-care centre
by: Puneet Bhatt, et al.
Published: (2015-11-01)

Bacteriocins, Antimicrobial Peptides from Bacterial Origin: Overview of their Biology and their Impact Against Multidrug-Resistant Bacteria
by: Alexis Simons, et al.
Published: (2020-04-01)

Multidrug Resistant Gram-Negative Bacilli as Nosocomial Infection Agents: Problems in Therapy and Recommudations for Management
by: Mehmet BAKIR
Published: (2002-09-01)

Bloodstream infections caused by multidrug-resistant gram-negative bacteria: epidemiological, clinical and microbiological features
by: Helena Ferreira Leal, et al.
Published: (2019-07-01)

Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients
by: Ayşe Karaaslan, et al.
Published: (2016-12-01)

Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
by: Zeinab Breijyeh, et al.
Published: (2020-03-01)

Clinical characteristics and outcomes of patients with multidrug-resistant Gram-negative bacterial infections treated with ceftazidime/avibactam
by: Huan Kuang, et al.
Published: (2020-12-01)

Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study
by: Shraddha Siwakoti, et al.
Published: (2018-09-01)

The effect of varying multidrug-resistence (MDR) definitions on rates of MDR gram-negative rods
by: Aline Wolfensberger, et al.
Published: (2019-11-01)

In Vitro Activities of Colistin and Sitafloxacin Combinations against Multidrug-, Carbapenem-, and Colistin-Resistant <i>Acinetobacter baumannii</i> Using the Broth Microdilution Checkerboard and Time-Kill Methods
by: Vipavee Rodjun, et al.
Published: (2020-08-01)

Carbapenem-resistant Gram-negative bacteria – analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012–2015
by: Heudorf, Ursel, et al.
Published: (2016-04-01)

Bi-Functional Alginate Oligosaccharide–Polymyxin Conjugates for Improved Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections
by: Joana Stokniene, et al.
Published: (2020-11-01)

High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis
by: Tafese B. Tufa, et al.
Published: (2020-08-01)

Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria?
by: Exner, Martin, et al.
Published: (2017-04-01)

In vitro activity of tigecycline against 313 Gram-positive and Gram-negative clinical isolates
by: Elisabetta Maioli, et al.
Published: (2010-03-01)

A multifunctional platform with single-NIR-laser-triggered photothermal and NO release for synergistic therapy against multidrug-resistant Gram-negative bacteria and their biofilms
by: Baohua Zhao, et al.
Published: (2020-04-01)

<title language="por">Multidrug efflux systems in Gram-negative bacteria
by: Maria Aparecida Scatamburlo Moreira, et al.
Published: (2004-06-01)

Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit
by: Delia Muntean, et al.
Published: (2018-11-01)

Proposal of a clinical score to stratify the risk of multidrug-resistant gram-negative rods bacteremia in cancer patients
by: Alberto A. Carena, et al.
Published: (2020-01-01)

Aerosolized Amikacin as Adjunctive Therapy of Ventilator-associated Pneumonia Caused by Multidrug-resistant Gram-negative Bacteria: A Single-center Randomized Controlled Trial
by: Chang Liu, et al.
Published: (2017-01-01)

Comparison of methods for the detection of in vitro synergy in multidrug-resistant gram-negative bacteria
by: Juliana Januario Gaudereto, et al.
Published: (2020-04-01)

RND-type Drug Efflux Pumps from Gram-negative bacteria: Molecular Mechanism and Inhibition
by: Henrietta eVenter, et al.
Published: (2015-04-01)

Antibacterial activities of the methanol extracts of Canarium schweinfurthii and four other Cameroonian dietary plants against multi-drug resistant Gram-negative bacteria
by: Joachim K. Dzotam, et al.
Published: (2016-09-01)

Lower Respiratory Tract Infections (LTRIs): An Insight into the Prevalence and the Antibiogram of the Gram Negative, Respiratory, Bacterial Agents
by: Syed Mustaq Ahmed, et al.
Published: (2013-02-01)

Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection
by: Mariana Lima Prata-Rocha, et al.

Active surveillance culture program in asymptomatic patients as a strategy to control multidrug-resistant gram-negative organisms: What should be considered?
by: Anucha Thatrimontrichai, et al.
Published: (2020-11-01)